Microsoft and Anthropic Reportedly in Talks for AI Chip Deal Following 5 Billion Investment UK Public Borrowing Hits Highest Level Since Covid Era in April as Retail Sales Decline Amid Fuel Price Surge SoftBank Group Shares Surge on Nvidia Earnings Highlighting AI Momentum Beyond Inc Acquires Buy Buy Baby Brand Rights Reuniting With Bed Bath Beyond SpaceX Starship V3 Test Flight Concludes with Planned Ocean Explosion April Jobs Report Expected to Show Cooling but Resilient Labor Market CI Q1 2026 Earnings EPS Misses Estimates as Stock Gains on Underlying Strength CHKP Q1 2026 Earnings EPS Beat Drives Shares Higher Amid Strong Cost Discipline LOAR Q1 2026 Earnings EPS Surges 108 Above Estimates Stock Rises Impinj Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher NCLH Q1 2026 Earnings Strong EPS Beat of 58 Surprises Analysts Yet Stock Declines HOWL Q1 2026 Earnings EPS Beats Estimates as Biotech Continues Pipeline Progress CervoMed Inc CRVO Edges Lower as Stock Tests Support Near 300 Stoneridge Inc SRI Stages Modest Rally Tests Key Resistance at 767 Balchem Corporation BCPC Holds Steady at 16175 Consolidation in a Tight Range CNX Resources Holds Near Support After Modest Decline Everest Group Ltd EG Slips 294 Assessing Support Levels and Sector Headwinds Ferrari Unveils First Fully Electric Model the Luce as Italian Marque Enters EV Era OGE Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Headwinds Jazz Pharmaceuticals JAZZ Experiences Modest Decline Following Recent RunUp IN8bio Inc INAB Q1 2026 Earnings EPS Surprise of 63 Highlights Cost Discipline in PreRevenue Biotech RDNW Q1 2026 Earnings NarrowerThanExpected Loss Exceeds Analyst Estimates urbangro Inc UGRO Q3 2025 Earnings Staggering Loss Shocks Market Amid Missing Revenue Data Mexco Energy MXC Q3 2025 Earnings Profitability Maintained Amid Industry Headwinds FCRX Q1 2026 Earnings Slight EPS Miss Reflects Stable but Unspectacular Quarter LOAR Q1 2026 Earnings EPS Surges 1087 Above Estimates Stock Edges Lower ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances